U.S. Luxury Stock News

Rocket Lab (RKLB) has just expanded its national security work by joining the U.S. Space Force’s NITE-STAR test and training contract and winning new roles on Viasat’s Protected Tactical SATCOM-Global program. See our latest analysis for Rocket Lab. Despite this contract momentum, Rocket Lab’s share price has been under pressure, with a 7 day share price return down 15.47% and a 90 day share price return down 55.46%, even as the 1 year total shareholder return is 39.02%. This suggests long...

Centrus Energy (NYSE:LEU) hosted Ohio Governor Mike DeWine and state leaders at its Piketon uranium enrichment facility to highlight an expansion of the plant. The visit focused on the role of the Piketon site in rebuilding the U.S. domestic nuclear fuel supply chain. State officials emphasized the potential for job creation and local economic activity tied to the facility's growth. The event reinforced the connection between Centrus Energy's expansion plans and broader U.S. energy and...

Dycom Industries (NYSE: DY) announced the resignation of board member Jennifer Fritzsche, effective immediately. The company said Fritzsche’s departure was not due to any disagreement with Dycom Industries. Following her resignation, the board of directors approved a reduction in its overall size. Board reshuffles often prompt investors to reassess governance quality across the sector. It can therefore be useful to compare Dycom Industries with a wider set of potentially undervalued peers...

Teradyne stock has surged over the past few years, yet current valuation checks suggest the shares lean expensive rather than obviously cheap. Teradyne has returned about 245.2% over the past 3 years, which puts pressure on today’s buyers to justify the price with continued strong execution. Recent enthusiasm around demand for Teradyne’s semiconductor test and robotics products can support high expectations, while any reset in AI related growth assumptions may quickly challenge how much...

Earlier this month, Cracker Barrel Old Country Store® rolled out a limited-time fall menu featuring $9.99 Crispy Homestyle Chicken Deals, caramel apple breakfast items, seasonal desserts and beverages, and a revived Free Kids Toy promotion aimed at families. This combination of value-focused comfort dishes and kid-centered rewards highlights Cracker Barrel's push to reinforce its family appeal and drive fall traffic. Next, we’ll explore how this refreshed Crispy Homestyle Chicken lineup and...

New 50% tariffs on Canadian imports following the breakdown in United States Canada trade talks have hit freight exposed stocks. ArcBest (ARCB) dropped as investors reassessed cross border supply chain risk. See our latest analysis for ArcBest. Even with the tariff shock, ArcBest’s recent share price moves show mixed momentum. The 1 month share price return is down 12.15%, while the year to date share price return is 75.66%, and the 1 year total shareholder return is 82.89%. If trade news has...

Lam Research (LRCX) is back in focus after announcing a plan to invest more than US$3b over five years to expand its global R&D lab network and increase experiment capacity by over 50%. See our latest analysis for Lam Research. Over the past year Lam Research has seen strong momentum, with a year to date share price return of 70.03% and a 1 year total shareholder return of 205.32%. However, the 7 day share price return declined 4.04% after recent sector pressure and profit taking. If you are...

Sea (NYSE:SE) drew fresh attention from investors after its second quarter 2026 results showed higher revenue and net income than a year earlier. This suggested firmer business momentum and improving profitability trends. See our latest analysis for Sea. Sea’s latest quarterly news has arrived alongside a sharp rebound in its share price, with a 1 month share price return of 23.18% and a 3 month share price return of 31.80%. However, the year to date share price return is still down 6.32% and...

Global Net Lease has delivered a strong 31.1% one year return, yet current valuation work suggests the stock may still trade below its estimated intrinsic value based on a Discounted Cash Flow (DCF) view and market multiples. Over the last 12 months, Global Net Lease has returned 31.1%, which puts fresh focus on whether the recent share price better reflects the underlying real estate portfolio. The acquisition of Modiv Industrial for US$535 million can support long term rental income from...

Long dated US Treasuries are back in the spotlight as Washington leans on buybacks and even the Treasury General Account to steady bond markets, while critics question what that means for long term yields and risk premia. For investors, that mix of policy experimentation and credibility concerns can reshuffle the winners and losers among US bond trading and fixed income market making banks. This article walks through three stocks from our screener that appear most exposed to this story and...

AppFolio’s AWS partnership and why it matters for investors AppFolio (APPF) recently named Amazon Web Services as its preferred cloud provider, formalising a collaboration that underpins its AI native Performance Platform and the Realm suite for nearly 23,000 real estate customers. See our latest analysis for AppFolio. AppFolio’s AWS announcement lands after a strong run in the share price, with a 30 day share price return of 36.38% and a 90 day share price return of 37.45%. However, the 1...

Monetary policy is back in the spotlight, with a push to shift the Federal Reserve away from interest rate targeting and toward strict control of credit growth. That kind of rule based approach could reshape how money flows through lenders and into the real economy, which matters for future borrowing costs and credit availability. This article walks through three U.S. nonbank and fintech lenders exposed to that debate, and explains how this policy rethink could influence their risk and reward...

Aurinia Pharmaceuticals recently entered into a settlement with Teva Pharmaceuticals resolving U.S. patent litigation over Teva’s proposed generic 7.9 mg voclosporin capsules, with Teva agreeing that Aurinia’s patents, expiring in December 2037, are valid, enforceable, and would be infringed by U.S. sales of its generic. The agreement, which restricts Teva from launching its generic voclosporin in the U.S. before December 7, 2036 (subject to contingencies and FDA approval), materially...

Everforth (EFOR) stock is in focus after its ECS unit secured a four year, US$30 million prime contract with the Defense Health Agency to support data driven IT modernization and analytics. See our latest analysis for Everforth. The recent four year Defense Health Agency contract has arrived during a sharp rebound in Everforth’s share price, with a 30 day share price return of 57.77% and a 90 day share price return of 68.74%. However, the 1 year total shareholder return is still down 38.59%...

AutoZone (AZO) has drawn fresh attention after its stock gained 1.74% on a weak market day, as investors focus on the company’s upcoming fourth quarter fiscal 2026 earnings and related conference call. See our latest analysis for AutoZone. That 1.74% one day share price gain comes after a mixed run for AutoZone, with the 30 day share price return of 1.76% set against a year to date share price decline of 8.91% and a 1 year total shareholder return that declined 27.31%, while the 5 year total...

Credicorp (NYSE:BAP) has drawn investor attention after reporting its second quarter and first half 2026 results. The company showed higher net interest income, net income and earnings per share than in the same periods last year. See our latest analysis for Credicorp. Credicorp's recent earnings release comes after a strong run, with a year to date share price return of 32.59% and a 1 year total shareholder return of 58.00%. The 3 year and 5 year total shareholder returns of 217.40% and...

ScanSource, Inc. has already reported full-year results for the period ended June 30, 2026, with sales rising to US$3.23 billion and net income improving to US$78.87 million, alongside higher basic and diluted earnings per share from continuing operations. Alongside these results, ScanSource issued guidance for fiscal 2027 calling for mid‑single‑ to high‑single‑digit net sales growth, while its Board adjusted to seven members following the retirement of long‑serving director Peter C...

In August 2026, Kaplan Fox & Kilsheimer LLP filed a past shareholder class action in the Southern District of New York against GoDaddy Inc., alleging that between September 3, 2025 and February 24, 2026 the company misled investors about its customer growth strategy and the impact of 2025 promotional discounts on bookings. The complaint centers on an alleged mismatch between GoDaddy’s public comments about rising average order size and an internal push for short-term, lower-value contracts...

Earlier this month, International Flavors & Fragrances released its “Inside the India GLP-1 Consumer Journey” report, detailing how GLP-1 usage is reshaping Indian consumers’ eating habits, nutrition priorities, and sensory preferences. The research points to consumers favoring smaller portions but higher-quality, better-tasting foods, signaling emerging product innovation opportunities for food and beverage brands that work with IFF. We’ll now explore how IFF’s insights into GLP-1-driven...

PPL Corporation previously declared a quarterly common stock dividend of US$0.2850 per share on August 21, 2026, payable on October 1, 2026, to shareowners of record as of September 10, 2026. Alongside this dividend, PPL outlined nearly US$5.10 billion of 2026 capital investments and US$23.00 billion through 2029, signaling a sizable commitment to grid and infrastructure spending backed by expanding revenues. We will now explore how PPL’s large multi‑year capital investment program could...

Ashland Inc. recently launched permexa sodium caprate, an intestinal permeation enhancer engineered to support scalable oral peptide, biologic and low-permeability drug products, including GLP-1 therapies. The product’s blend of permeability enhancement with improved powder flow and tablet compressibility offers a differentiated excipient solution for complex oral biologic formulations and manufacturing. We’ll now explore how Ashland’s permexa sodium caprate launch, aimed at oral biologics...

On July 28, 2026, BXP reported second-quarter results that exceeded analyst expectations and raised the midpoint of its full-year 2026 FFO outlook, citing improving business fundamentals. This combination of stronger-than-anticipated earnings and a higher FFO forecast highlighted management’s increased confidence in the company’s operating trajectory and cash flow visibility. Next, we’ll examine how BXP’s upgraded full-year FFO outlook shapes its existing investment narrative and risk‑reward...

Legend Biotech Corporation recently reported its second-quarter 2026 results, with revenue rising to US$387.5 million from US$255.1 million and net income turning to US$33.2 million from a net loss of US$125.4 million a year earlier. Over the first half of 2026, revenue increased to US$692.6 million while the company sharply reduced its net loss to US$21.1 million, highlighting a rapid improvement in profitability metrics. With Legend Biotech’s latest quarter showing a shift to...

NNN REIT (NNN) drew fresh attention after appointing Christina Chiu and Charles D. Mueller Jr. to its Board of Directors, a planned succession move related to the forthcoming retirement of director Betsy D. Holden. See our latest analysis for NNN REIT. Alongside the board refresh, NNN REIT’s recent 1-day share price return of 1.11% and year to date share price return of 17.23% come after a 30 day share price decline of 6.16%. Its 1-year total shareholder return of 16.62% and 5-year total...